GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anxo Pharmaceutical Co Ltd (ROCO:6677) » Definitions » PB Ratio

Anxo Pharmaceutical Co (ROCO:6677) PB Ratio : 3.09 (As of Apr. 28, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Anxo Pharmaceutical Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-28), Anxo Pharmaceutical Co's share price is NT$45.35. Anxo Pharmaceutical Co's Book Value per Share for the quarter that ended in Jun. 2023 was NT$14.69. Hence, Anxo Pharmaceutical Co's PB Ratio of today is 3.09.

Good Sign:

Anxo Pharmaceutical Co Ltd stock PB Ratio (=2.95) is close to 1-year low of 2.95

The historical rank and industry rank for Anxo Pharmaceutical Co's PB Ratio or its related term are showing as below:

ROCO:6677' s PB Ratio Range Over the Past 10 Years
Min: 1.16   Med: 2.28   Max: 4.93
Current: 3.07

During the past 10 years, Anxo Pharmaceutical Co's highest PB Ratio was 4.93. The lowest was 1.16. And the median was 2.28.

ROCO:6677's PB Ratio is ranked worse than
69.33% of 962 companies
in the Drug Manufacturers industry
Industry Median: 1.925 vs ROCO:6677: 3.07

During the past 12 months, Anxo Pharmaceutical Co's average Book Value Per Share Growth Rate was 5.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 4.20% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 5.10% per year.

During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Anxo Pharmaceutical Co was 7.00% per year. The lowest was -14.50% per year. And the median was 5.00% per year.

Back to Basics: PB Ratio


Anxo Pharmaceutical Co PB Ratio Historical Data

The historical data trend for Anxo Pharmaceutical Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anxo Pharmaceutical Co PB Ratio Chart

Anxo Pharmaceutical Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.67 2.40 1.89 1.62 1.97

Anxo Pharmaceutical Co Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.67 1.62 1.40 1.97 4.87

Competitive Comparison of Anxo Pharmaceutical Co's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Anxo Pharmaceutical Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anxo Pharmaceutical Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Anxo Pharmaceutical Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Anxo Pharmaceutical Co's PB Ratio falls into.



Anxo Pharmaceutical Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Anxo Pharmaceutical Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2023)
=45.35/14.692
=3.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Anxo Pharmaceutical Co  (ROCO:6677) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Anxo Pharmaceutical Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Anxo Pharmaceutical Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Anxo Pharmaceutical Co (ROCO:6677) Business Description

Traded in Other Exchanges
N/A
Address
8th Floor-3, Nanjing East Road, No. 206, Section 2, Taipei City, TWN
Anxo Pharmaceutical Co Ltd is a drug manufacturer. The company is engaged in developing drugs which include prescription medication and consumer healthcare medication. The products of the company include cardiovascular system medication, central nervous system medication, diabetes medication, infectious medicine, and dermatology medication.

Anxo Pharmaceutical Co (ROCO:6677) Headlines

No Headlines